Log In
BCIQ
Print this Print this
 

MAP4343

  Manage Alerts
Collapse Summary General Information
Company Mapreg S.A.S.
DescriptionDerivative of the neurosteriod pregnenolone, which stimulates microtubule associated protein type 2 (MAP2)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today